ÂÜÀòÂÒÂ×

Martina Canestraro is an experienced biopharmaceutical professional currently serving as the Director at Affini-T Therapeutics since November 2022. Prior to this role, Martina held the position of Associate Director at 2seventy bio for one year and contributed as a Senior Scientist, where responsibilities included leading preclinical safety strategies and overseeing in vivo and in vitro studies. At bluebird bio, Martina served as a Senior Scientist, focusing on in vitro safety assessment and managing CRO relationships, after a role as Scientist II leading a laboratory team. Previous experience includes positions at Immunocore Limited, where significant contributions involved high-throughput assay development for cancer immunotherapy, and early career research roles at Università di Pisa/S. Chiara University hospital and New York Medical College. Martina holds a Ph.D. in Immunity and Infection from the University of Birmingham and a Master's Degree in Medicinal and Pharmaceutical Chemistry from Università di Pisa.